Get the Stockscreener App
17.73
0.06%
-0.010
After Hours:
17.73
Neogenomics Inc Stock (NEO) Forecast
The Neogenomics Inc (NEO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.31, representing a +8.93% increase from the current price of $17.73. The highest analyst price target is $21.56, and the lowest is $17.07.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NEO Price Target
Average 24.45
(+37.88% Upside)
Is Neogenomics Inc (NEO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 74.94 | Sell |
| STOCH(9,6) | 83.43 | Sell |
| STOCHRSI(14) | 99.30 | Sell |
| MACD(12,26) | 0.7509 | Buy |
| ADX(14) | 31.46 | Buy |
| William %R | -7.5949 | Sell |
| CCI(14) | 112.09 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
16.21
Buy
|
16.61
Buy
|
| MA20 |
15.86
Buy
|
15.93
Buy
|
| MA50 |
14.71
Buy
|
15.28
Buy
|
| MA100 |
15.35
Buy
|
15.12
Buy
|
| MA200 |
14.94
Buy
|
15.11
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, NEO could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on NEO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 74.94 indicates that NEO is overbought. This suggests that NEO price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 83.43 indicates that NEO is oversold. This means that NEO price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 99.3 indicates that NEO is oversold. This suggests that NEO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.46 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 112.09 indicates that NEO is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term NEO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neogenomics Inc financial reports and earnings history, Neogenomics Inc (NEO) stock could reach $6.7168 by 2030, $2.5963 by 2040 and $16.62 by 2050. See the projected annual prices until 2050 of the Neogenomics Inc stock below:
- Neogenomics Inc (NEO) is expected to reach an average price of $7.7933 in 2035, with a high prediction of $8.2933 and a low estimate of $1.7733. This indicates an $-56.04% rise from the last recorded price of $17.73.
- Neogenomics Inc (NEO) stock is projected to chart a bullish course in 2040, with an average price target of $3.8013, representing an $-78.56% surge from its current level. The forecast ranges from a conservative $3.4563 to a sky-high $2.5963.
- Our analysts predict Neogenomics Inc (NEO) to jump 0.70% by 2045, soaring from $16.57 to an average price of $17.85, potentially reaching $16.87. While $16.57 is the low estimate, the potential upside is significant.
- Neogenomics Inc (NEO) stock is expected to climb by 2050, reaching an average of $16.66, a $-6.06% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.62 and $14.11, respectively, highlighting the market's uncertainty.
Neogenomics Inc Stock (NEO) Year by Year Forecast
Neogenomics Inc Stock (NEO) Price Forecast for 2025
Neogenomics Inc Stock (NEO) is expected to reach an average price of $24.45 in 2025, with a high prediction of $36.71 and a low estimate of $12.18. This indicates an +37.88% rise from the last recorded price of $17.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $20.86 | $17.07 | $21.56 | +17.68% |
| February, 2025 | $23.90 | $20.15 | $26.08 | +34.80% |
| March, 2025 | $19.96 | $15.61 | $26.64 | +12.56% |
| April, 2025 | $19.31 | $12.18 | $23.20 | +8.89% |
| May, 2025 | $20.22 | $15.81 | $21.28 | +14.03% |
| June, 2025 | $20.21 | $17.15 | $23.21 | +13.98% |
| July, 2025 | $20.23 | $17.06 | $21.20 | +14.11% |
| August, 2025 | $27.79 | $19.12 | $28.82 | +56.76% |
| September, 2025 | $31.67 | $26.01 | $33.02 | +78.63% |
| October, 2025 | $27.85 | $26.67 | $32.97 | +57.07% |
| November, 2025 | $28.99 | $26.26 | $30.35 | +63.49% |
| December, 2025 | $31.38 | $27.85 | $36.71 | +77.01% |
Neogenomics Inc Stock (NEO) Price Forecast for 2026
The predicted value for Neogenomics Inc (NEO) in 2026 is set at an average of $41.22. Estimates vary from a peak of $53.92 to a trough of $28.51, indicating an +132.46% surge from the present price of $17.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $39.56 | $29.91 | $39.75 | +123.13% |
| February, 2026 | $45.89 | $38.47 | $46.64 | +158.81% |
| March, 2026 | $45.07 | $41.16 | $49.33 | +154.23% |
| April, 2026 | $48.91 | $43.48 | $53.92 | +175.88% |
| May, 2026 | $42.58 | $33.13 | $48.33 | +140.16% |
| June, 2026 | $40.62 | $35.76 | $43.86 | +129.08% |
| July, 2026 | $30.61 | $28.51 | $44.77 | +72.67% |
| August, 2026 | $35.65 | $29.02 | $36.01 | +101.08% |
| September, 2026 | $37.84 | $34.74 | $40.00 | +113.42% |
| October, 2026 | $39.41 | $34.13 | $41.32 | +122.26% |
| November, 2026 | $41.32 | $33.16 | $42.48 | +133.07% |
| December, 2026 | $40.98 | $37.51 | $46.18 | +131.14% |
Neogenomics Inc Stock (NEO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neogenomics Inc (NEO) is $23.81, with a high forecast of $47.51 and a low forecast of $0.1139. This indicates an +34.31% increase from the last price of $17.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $37.65 | $33.54 | $47.51 | +112.34% |
| February, 2027 | $32.89 | $30.60 | $39.96 | +85.48% |
| March, 2027 | $27.02 | $22.56 | $33.37 | +52.42% |
| April, 2027 | $17.90 | $16.99 | $28.33 | +0.96% |
| May, 2027 | $14.47 | $12.68 | $17.43 | -18.40% |
| June, 2027 | $12.59 | $10.56 | $16.80 | -29.02% |
| July, 2027 | $5.2621 | $4.1121 | $13.00 | -70.32% |
| August, 2027 | $4.3888 | $4.1888 | $7.5455 | -75.25% |
| September, 2027 | $2.1072 | $0.4539 | $4.7305 | -88.11% |
| October, 2027 | $0.8139 | $0.1139 | $2.0923 | -95.41% |
| November, 2027 | $2.2507 | $0.5956 | $3.1773 | -87.31% |
| December, 2027 | $5.9891 | $1.104 | $6.2691 | -66.22% |
Neogenomics Inc Stock (NEO) Price Forecast for 2028
In 2028, Neogenomics Inc (NEO) is projected to reach an average price of $7.4527, with a high projection of $14.42 and a low estimate of $0.4825. This indicates an -57.97% fall from the last price of $17.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.2158 | $3.0058 | $6.3607 | -81.86% |
| February, 2028 | $2.0725 | $1.6875 | $4.2174 | -88.31% |
| March, 2028 | $1.1259 | $0.4825 | $2.9042 | -93.65% |
| April, 2028 | $3.8276 | $0.5026 | $5.5459 | -78.41% |
| May, 2028 | $2.796 | $2.666 | $6.6643 | -84.23% |
| June, 2028 | $4.8527 | $2.3377 | $5.8727 | -72.63% |
| July, 2028 | $6.1294 | $4.3594 | $7.1877 | -65.43% |
| August, 2028 | $10.55 | $6.0311 | $12.85 | -40.51% |
| September, 2028 | $8.7345 | $8.3945 | $13.30 | -50.74% |
| October, 2028 | $9.1813 | $7.7113 | $10.30 | -48.22% |
| November, 2028 | $11.91 | $8.9929 | $14.42 | -32.83% |
| December, 2028 | $10.05 | $9.6664 | $11.73 | -43.34% |
Neogenomics Inc Stock (NEO) Price Forecast for 2029
The 2029 price forecast for Neogenomics Inc Stock (NEO) is $9.5875 on average, with a high prediction of $15.54 and a low estimate of $3.64. This represents an -45.92% decrease from the previous price of $17.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.36 | $9.0831 | $12.39 | -35.90% |
| February, 2029 | $8.0015 | $7.3698 | $11.62 | -54.87% |
| March, 2029 | $7.5882 | $7.1882 | $9.6348 | -57.20% |
| April, 2029 | $6.6749 | $5.1932 | $7.6299 | -62.35% |
| May, 2029 | $9.9933 | $6.4366 | $11.32 | -43.64% |
| June, 2029 | $13.28 | $9.61 | $14.04 | -25.10% |
| July, 2029 | $10.51 | $10.19 | $15.54 | -40.74% |
| August, 2029 | $9.2351 | $9.1751 | $11.01 | -47.91% |
| September, 2029 | $11.22 | $8.1785 | $11.92 | -36.71% |
| October, 2029 | $9.7003 | $8.7903 | $11.55 | -45.29% |
| November, 2029 | $8.067 | $7.957 | $10.41 | -54.50% |
| December, 2029 | $5.11 | $3.64 | $10.61 | -71.18% |
Neogenomics Inc Stock (NEO) Price Forecast for 2030
Neogenomics Inc Stock (NEO) is expected to reach an average price of $9.8567 in 2030, with a high forecast of $18.32 and a low forecast of $1.3972. This signifies an -44.41% decrease from the last price of $17.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.6078 | $3.0977 | $6.7168 | -68.37% |
| February, 2030 | $4.6302 | $3.5935 | $7.1902 | -73.88% |
| March, 2030 | $8.0237 | $4.6036 | $8.6537 | -54.75% |
| April, 2030 | $7.5771 | $6.217 | $9.5637 | -57.26% |
| May, 2030 | $2.0439 | $1.6139 | $8.0405 | -88.47% |
| June, 2030 | $2.8673 | $1.3972 | $3.4973 | -83.83% |
| July, 2030 | $7.5141 | $3.0707 | $7.7241 | -57.62% |
| August, 2030 | $11.67 | $7.5475 | $12.14 | -34.19% |
| September, 2030 | $13.28 | $11.00 | $13.55 | -25.09% |
| October, 2030 | $17.51 | $12.63 | $18.16 | -1.25% |
| November, 2030 | $8.0062 | $3.8912 | $18.32 | -54.84% |
| December, 2030 | $7.5996 | $3.9446 | $12.32 | -57.14% |
0.41%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):